Opendata, web and dolomites

ERACHRON SIGNED

Eradicating Chronic Infections

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ERACHRON project word cloud

Explore the words cloud of the ERACHRON project. It provides you a very rough idea of what is the project "ERACHRON" about.

resistant    infections    molecules    chemical    regulated    synthesis    structural    community    biochemical    pathogen    treatment    progression    selective    prevent    stringent    persister    molecular    genetically    last    screening    insurgence    revert    urgent    regulation    cellular    bacterial    modulate    experimental    allosterically    shut    nmr    dormant    possibly    biological    fragment    ad    ultimately    gap    upcoming    time    appear    phenotype    subpopulation    resurgence    decades    mechanisms    potent    drugs    intrinsically    antibiotic    operate    events    complementary    reservoir    alarming    elusive    sustains    simply    overarching    synergy    exploitable    insensitive    sites    cascade    protein    dynamic    structure    persisters    spectroscopy    chronic    drug    unravelled    survival    pharmacological    sr    play    sensitive    tools    eradication    off    relapsing    predictions    tolerant    infection    chemists    switch    propensity    highlight    designed    privileged    awake    fill    virtual    suggests    hoc    pivotal    unaffected    trigger    small    combined   

Project "ERACHRON" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI MILANO 

Organization address
address: Via Festa Del Perdono 7
city: MILANO
postcode: 20122
website: www.unimi.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 1˙500˙000 €
 EC max contribution 1˙500˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI MILANO IT (MILANO) coordinator 1˙500˙000.00

Map

 Project objective

'Given the alarming progression of chronic and relapsing infections in the last decades, and the even more alarming predictions for the upcoming years, it is urgent for chemists to be able to provide new molecular tools to study, and ultimately solve, these complex biological problems. Bacterial persisters are an elusive 'dormant' phenotype that play a pivotal role in chronic infections, with mechanisms that remain to be fully unravelled. Current knowledge suggests that bacterial persisters are not genetically resistant to antibiotic treatment; they simply appear to shut down through a cascade of biochemical events called the stringent response (SR), becoming insensitive to current drugs. This subpopulation remains unaffected during the time of pharmacological treatment and represents a reservoir that sustains pathogen survival and resurgence. The goal of this project is to fill the knowledge gap between persisters formation and infection eradication, providing the community with potent and selective small molecular tools that can be used to challenge complementary survival mechanisms. I will adopt a combined approach targeting a specific cellular trigger of the persister phenotype with small molecules designed ad hoc in order to switch it off. The target is a bacterial protein involved in the SR cascade, whose activity is proposed to be allosterically regulated. Coordination propensity analysis of the dynamic behaviour of the target will highlight regulation sites exploitable to modulate and control the protein activity. Structure-based design, virtual fragment screening and chemical synthesis will operate in synergy. Experimental screening methodologies intrinsically rich in structural information, such as those based on NMR spectroscopy, will be privileged. The overarching goal is to identify molecules able to prevent the insurgence of the 'dormant' drug-tolerant state and, possibly, revert the persisters already present to the 'awake' drug-sensitive phenotype.

'

 Publications

year authors and title journal last update
List of publications.
2019 Gabriele Conti, Marco Minneci, Sara Sattin
Optimised Synthesis of the Bacterial Magic Spot (p)ppGpp Chemosensor PyDPA
published pages: , ISSN: 1439-4227, DOI: 10.1002/cbic.201900013
ChemBioChem 2019-09-02

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ERACHRON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ERACHRON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

HyperBio (2019)

Vis-NIR Hyperspectral imaging for biomaterial quality control

Read More  

BALANCE (2019)

Mapping Dispersion Spectroscopically in Large Gas-Phase Molecular Ions

Read More  

OSIRIS (2020)

Automatic measurement of speech understanding using EEG

Read More